On the upside
Ford (NYSE: F) is expected to report its first year-over-year gain in monthly auto sales due in part to the popularity of the "cash for clunkers" program to get consumers to upgrade to fuel-efficient cars.
Shares of Keryx Biopharmaceuticals (Nasdaq: KERX) rose after the FDA allowed the company to move forward with late-stage study of its cancer drug candidate.
An analyst upgraded Deltek (Nasdaq: PROJ) whose shares recently rallied. The company provides project management business software.
On the downside
Shares of Huron Consulting Group (Nasdaq: HURN) tumbled in a dramatic fashion after the company lowered its guidance, announced that it would restate results, and accepted the resignations of its CEO and CFO.
Savient Pharmaceuticals (Nasdaq: SVNT) failed to win approval by the FDA for its drug treatment of chronic gout.
In the broad market, advancing issues outpaced decliners by a margin of more than 4 to 1 on the NYSE and by a margin of nearly 3 to 1 on Nasdaq. The Russell 2000 which tracks small cap stocks added 5 points to 562.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here